Last Friday, the FDA granted emergency use authorization (EUA) to Gilead Sciences, Inc. (NASDAQ:GILD) remdesivir to treat patients hospitalized with COVID19. The EUA approval came within days after Gilead and NIH scientists released clinical study results demonstrating the statistical significance […]